191 related articles for article (PubMed ID: 810067)
1. [Genetic study of GM2 gangliosidosis (Tay-Sachs and Sandhoff) by the study of the hexosaminidases of the Sandhoff-rodents hybrids (mouse and hamster)].
Weil D; Van Cong N; Rebourcet R; Frézal J
Ann Genet; 1975 Sep; 18(3):163-8. PubMed ID: 810067
[TBL] [Abstract][Full Text] [Related]
2. A study of hexosaminadases in interspecific hybrids and in GM2 gangliosidosis with a discussion on their genetic control.
Van Cong N; Weil D; Rebourcet R; Frézal J; Richard-Mollard AM
Ann Hum Genet; 1975 Jul; 39(1):111-23. PubMed ID: 810068
[TBL] [Abstract][Full Text] [Related]
3. Tay-Sachs and Sandhoff diseases: an hypothesis about the primary lesion based on hexosaminidase patterns in interspecific hybrids.
Van Cong N; Weil D; Rebourcet R; Pangalos C; Frézal J
Birth Defects Orig Artic Ser; 1975; 11(3):272-5. PubMed ID: 812570
[No Abstract] [Full Text] [Related]
4. Hexosaminidase isozyme in type O Gm2 gangliosidosis (Sandhoff-Jatzkewitz disease).
Beutler E; Kuhl W; Comings D
Am J Hum Genet; 1975 Sep; 27(5):628-38. PubMed ID: 808963
[TBL] [Abstract][Full Text] [Related]
5. [Reconstruction of hexosaminidase isoenzymes during hybridization of fibroblasts from Tay-Sachs and Sandhoff diseases].
Beĭer EM; Vidershaĭn GIa; Venert M
Biull Eksp Biol Med; 1984 Jan; 97(1):83-6. PubMed ID: 6229294
[TBL] [Abstract][Full Text] [Related]
6. Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis.
Sango K; McDonald MP; Crawley JN; Mack ML; Tifft CJ; Skop E; Starr CM; Hoffmann A; Sandhoff K; Suzuki K; Proia RL
Nat Genet; 1996 Nov; 14(3):348-52. PubMed ID: 8896570
[TBL] [Abstract][Full Text] [Related]
7. Juvenile Sandhoff Disease: complementation tests with Sandhoff and Tay-Sachs disease using polyethylene glycol-induced cell fusion.
Wood S
Hum Genet; 1978 Apr; 41(3):325-9. PubMed ID: 417993
[TBL] [Abstract][Full Text] [Related]
8. Characterization of polypeptides serologically and structurally related to hexosaminidase in cultured fibroblasts.
Tsui F; Mahuran DJ; Lowden JA; Mosmann T; Gravel RA
J Clin Invest; 1983 Apr; 71(4):965-73. PubMed ID: 6833496
[TBL] [Abstract][Full Text] [Related]
9. Steroid hexosaminidase activity in Tay-Sachs and Sandhoff-Jatzkewitz diseases.
Tomasi LG; Fukushima DK; Kolodny EH
Neurology; 1974 Dec; 24(12):1158-65. PubMed ID: 4280528
[No Abstract] [Full Text] [Related]
10. Characterization of the testis and epididymis in mouse models of human Tay Sachs and Sandhoff diseases and partial determination of accumulated gangliosides.
Trasler J; Saberi F; Somani IH; Adamali HI; Huang JQ; Fortunato SR; Ritter G; Gu M; Aebersold R; Gravel RA; Hermo L
Endocrinology; 1998 Jul; 139(7):3280-8. PubMed ID: 9645704
[TBL] [Abstract][Full Text] [Related]
11. Tay-Sachs and Sandhoff diseases: an hypothesis about the primary lesion based on hexosaminidase patterns in interspecific hybrids.
Cong NV; Weil D; Rebourcet R; Pangalos C; Frézal J
Cytogenet Cell Genet; 1975; 14(3-6):442-5. PubMed ID: 1192834
[No Abstract] [Full Text] [Related]
12. beta-hexosaminidase lentiviral vectors: transfer into the CNS via systemic administration.
Kyrkanides S; Miller JH; Brouxhon SM; Olschowka JA; Federoff HJ
Brain Res Mol Brain Res; 2005 Feb; 133(2):286-98. PubMed ID: 15710246
[TBL] [Abstract][Full Text] [Related]
13. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism.
Sango K; Yamanaka S; Hoffmann A; Okuda Y; Grinberg A; Westphal H; McDonald MP; Crawley JN; Sandhoff K; Suzuki K; Proia RL
Nat Genet; 1995 Oct; 11(2):170-6. PubMed ID: 7550345
[TBL] [Abstract][Full Text] [Related]
14. Tay-Sachs and Sandhoff-Jatzkewitz diseases: complementation of hexosaminidase A deficiency by somatic cell hybridization.
Rattazzi MC; Brown JA; Davidson RG; Shows TB
Birth Defects Orig Artic Ser; 1975; 11(3):232-5. PubMed ID: 812568
[No Abstract] [Full Text] [Related]
15. The lysosomal hexosaminidase isozymes.
Mahuran D; Novak A; Lowden JA
Isozymes Curr Top Biol Med Res; 1985; 12():229-88. PubMed ID: 3886595
[TBL] [Abstract][Full Text] [Related]
16. Metabolic correction in microglia derived from Sandhoff disease model mice.
Tsuji D; Kuroki A; Ishibashi Y; Itakura T; Itoh K
J Neurochem; 2005 Sep; 94(6):1631-8. PubMed ID: 16092933
[TBL] [Abstract][Full Text] [Related]
17. Lyso-GM2 ganglioside: a possible biomarker of Tay-Sachs disease and Sandhoff disease.
Kodama T; Togawa T; Tsukimura T; Kawashima I; Matsuoka K; Kitakaze K; Tsuji D; Itoh K; Ishida Y; Suzuki M; Suzuki T; Sakuraba H
PLoS One; 2011; 6(12):e29074. PubMed ID: 22205997
[TBL] [Abstract][Full Text] [Related]
18. The expression of hex A and hex B isozymes of hexosaminidase in parental and experimental human fibroblast cells and their components.
Bladon MT
Biochem Genet; 1981 Oct; 19(9-10):971-86. PubMed ID: 7332532
[TBL] [Abstract][Full Text] [Related]
19. Human recombinant lysosomal β-Hexosaminidases produced in Pichia pastoris efficiently reduced lipid accumulation in Tay-Sachs fibroblasts.
Espejo-Mojica AJ; Rodríguez-López A; Li R; Zheng W; Alméciga-Díaz CJ; Dulcey-Sepúlveda C; Combariza G; Barrera LA
Am J Med Genet C Semin Med Genet; 2020 Dec; 184(4):885-895. PubMed ID: 33111489
[TBL] [Abstract][Full Text] [Related]
20. [GM2 gangliosidosis diagnosis and carriers detection by fractionation of N-acetyl-beta-D-hexosaminidase by electrophoresis on cellulose acetate gel (author's transl)].
Pampols T; Girós ML; González Sastre F; Sabater J
An Esp Pediatr; 1977 Oct; 10(10):695-704. PubMed ID: 607830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
